Fei Jianjiang - Net Worth and Insider Trading

Fei Jianjiang Net Worth

The estimated net worth of Fei Jianjiang is at least $82 Million dollars as of 2024-06-21. Fei Jianjiang is the 2201 Interest of corporation controlled by you of CStone Pharmaceuticals and owns about 75,553,730 shares of CStone Pharmaceuticals (HKSE:02616) stock worth over $82 Million. Details can be seen in Fei Jianjiang's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Fei Jianjiang has not made any transactions after 2023-07-13 and currently still holds the listed stock(s).

Transaction Summary of Fei Jianjiang

To

Fei Jianjiang Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Fei Jianjiang owns 1 companies in total, including CStone Pharmaceuticals (HKSE:02616) .

Click here to see the complete history of Fei Jianjiang’s form 4 insider trades.

Insider Ownership Summary of Fei Jianjiang

Ticker Comapny Transaction Date Type of Owner
HKSE:02616 CStone Pharmaceuticals 2023-07-13 2201 Interest of corporation controlled by you

Fei Jianjiang Latest Holdings Summary

Fei Jianjiang currently owns a total of 1 stock. Fei Jianjiang owns 75,553,730 shares of CStone Pharmaceuticals (HKSE:02616) as of July 13, 2023, with a value of $82 Million.

Latest Holdings of Fei Jianjiang

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HKSE:02616 CStone Pharmaceuticals 2023-07-13 75,553,730 1.09 82,353,566

Holding Weightings of Fei Jianjiang


Fei Jianjiang Form 4 Trading Tracker

According to the SEC Form 4 filings, Fei Jianjiang has made a total of 4 transactions in CStone Pharmaceuticals (HKSE:02616) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in CStone Pharmaceuticals is the sale of 3,712,914 shares on July 13, 2023, which brought Fei Jianjiang around $9 Million.

Insider Trading History of Fei Jianjiang

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Fei Jianjiang Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Fei Jianjiang Ownership Network

Ownership Network List of Fei Jianjiang

No Data

Ownership Network Relation of Fei Jianjiang

Insider Network Chart

Fei Jianjiang Owned Company Details

What does CStone Pharmaceuticals do?

Who are the key executives at CStone Pharmaceuticals?

Fei Jianjiang is the 2201 Interest of corporation controlled by you of CStone Pharmaceuticals. Other key executives at CStone Pharmaceuticals include 2101 Beneficial owner Yang Jianxin , 2101 Beneficial owner Su Zhou Gong Ye Yuan Qu Zheng Ze Yuan Shi Chuang Ye Tou Zi Qi Ye You Xian He Huo , and 2201 Interest of corporation controlled by you Su Zhou Gong Ye Yuan Qu Zheng Ze Ji Ming Gu Quan Tou Zi Guan Li You Xian Gong Si .

CStone Pharmaceuticals (HKSE:02616) Insider Trades Summary

Over the past 18 months, Fei Jianjiang made 3 insider transaction in CStone Pharmaceuticals (HKSE:02616) with a net sale of 17,667,742. Other recent insider transactions involving CStone Pharmaceuticals (HKSE:02616) include a net sale of 0 shares made by Morgan Stanley , a net sale of 17,667,742 shares made by Su Zhou Gong Ye Yuan Qu Zheng Ze Yuan Shi Chuang Ye Tou Zi Qi Ye You Xian He Huo , and a net sale of 17,667,742 shares made by Su Zhou Gong Ye Yuan Qu Guan Wei Hui .

In summary, during the past 3 months, insiders sold 0 shares of CStone Pharmaceuticals (HKSE:02616) in total and bought 350,000 shares, with a net purchase of 350,000 shares. During the past 18 months, 141,341,936 shares of CStone Pharmaceuticals (HKSE:02616) were sold and 350,000 shares were bought by its insiders, resulting in a net sale of 140,991,936 shares.

CStone Pharmaceuticals (HKSE:02616)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

CStone Pharmaceuticals Insider Transactions

No Available Data

Fei Jianjiang Mailing Address

Above is the net worth, insider trading, and ownership report for Fei Jianjiang. Currently GuruFocus does not have mailing address information for Fei Jianjiang.

Discussions on Fei Jianjiang

No discussions yet.